Skip to main content

Fungal Infections News

Related terms: Fungal Infection, Infection, Fungal

Zicam and Orajel Swabs Recalled for Possible Fungal Contamination

THURSDAY, June 12, 2025 — Some nasal and baby teething swabs from Zicam and Orajel are being recalled across the country because they may be contaminated with fungus, U.S. health officials said. The r...

Midea Recalls 1.7 Million AC Units Over Mold Risk

WEDNESDAY, June 11, 2025 — More than 1.7 million window air conditioners are being recalled because of a risk for mold growth, which can lead to serious health problems. The affected units are made b...

Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.

FRIDAY, Nov. 15, 2024 – The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and increasing, according to a study published online Oct....

Expanded Admission Screening Protocol for Candida Auris Beneficial

FRIDAY, Nov. 8, 2024 – Health care facilities should consider initiating or expanding admission screening for Candida auris based on community prevalence rates, according to a study published online ...

First Cases of Sexually Transmitted Ringworm Reported in the U.S.

THURSDAY, Oct. 31, 2024 – Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm (Trichophyton mentagrophytes). Until now, transmission of the fungal...

Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash

THURSDAY, Oct. 31, 2024 – Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty rash that can take months to bring under...

FDA Medwatch Alert: Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity

ISSUE: Sagent has initiated a voluntary recall of one lot of Fluconazole Injection, USP, 200mg per 100mL to the user level due to the discovery of an out of specification impurity result detected...

FDA Approves Cresemba (isavuconazonium sulfate) For Fungal Infections

March 6, 2015 – The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

fluconazole